Clinical Laserthermia Systems AB (publ) (CLS-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.161x

Based on the latest financial reports, Clinical Laserthermia Systems AB (publ) (CLS-B) has a cash flow conversion efficiency ratio of -0.161x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.69 Million ≈ $-1.15 Million USD) by net assets (Skr66.48 Million ≈ $7.15 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CLS-B net asset quality index to measure how much of total assets are equity-financed.

Clinical Laserthermia Systems AB (publ) - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Clinical Laserthermia Systems AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Clinical Laserthermia Systems AB (publ) total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Clinical Laserthermia Systems AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinical Laserthermia Systems AB (publ) ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
PLAYWITH Inc
KQ:023770
-0.027x
Rossi Residencial S.A
SA:RSID3
-0.033x
Balkrishna Paper Mills Limited
NSE:BALKRISHNA
0.020x
American Uranium Ltd
AU:AMU
-0.035x
Tsodilo Resources Limited
V:TSD
-0.026x
Armada Berjaya Trans Tbk PT
JK:JAYA
0.080x
AUXICO RESOURCES CANADA
F:A0H
N/A
Spectrumone publ AB
ST:SPEONE
-0.116x

Annual Cash Flow Conversion Efficiency for Clinical Laserthermia Systems AB (publ) (2008–2025)

The table below shows the annual cash flow conversion efficiency of Clinical Laserthermia Systems AB (publ) from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Clinical Laserthermia Systems AB (publ).

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr66.48 Million
≈ $7.15 Million
Skr-33.20 Million
≈ $-3.57 Million
-0.499x +41.89%
2024-12-31 Skr65.69 Million
≈ $7.07 Million
Skr-56.45 Million
≈ $-6.08 Million
-0.859x +43.70%
2023-12-31 Skr43.53 Million
≈ $4.68 Million
Skr-66.45 Million
≈ $-7.15 Million
-1.527x +83.01%
2022-12-31 Skr7.87 Million
≈ $846.40K
Skr-70.69 Million
≈ $-7.61 Million
-8.988x -187.72%
2021-12-31 Skr21.18 Million
≈ $2.28 Million
Skr-66.17 Million
≈ $-7.12 Million
-3.124x +21.47%
2020-12-31 Skr13.93 Million
≈ $1.50 Million
Skr-55.41 Million
≈ $-5.96 Million
-3.978x +28.85%
2019-12-31 Skr7.00 Million
≈ $752.99K
Skr-39.12 Million
≈ $-4.21 Million
-5.591x -619.15%
2018-12-31 Skr49.81 Million
≈ $5.36 Million
Skr-38.72 Million
≈ $-4.17 Million
-0.777x -5.20%
2017-12-31 Skr33.00 Million
≈ $3.55 Million
Skr-24.39 Million
≈ $-2.62 Million
-0.739x +35.74%
2016-12-31 Skr17.06 Million
≈ $1.84 Million
Skr-19.63 Million
≈ $-2.11 Million
-1.150x -19.85%
2015-12-31 Skr19.46 Million
≈ $2.09 Million
Skr-18.68 Million
≈ $-2.01 Million
-0.960x -92.50%
2014-12-31 Skr31.58 Million
≈ $3.40 Million
Skr-15.74 Million
≈ $-1.69 Million
-0.499x +28.93%
2013-12-31 Skr26.09 Million
≈ $2.81 Million
Skr-18.30 Million
≈ $-1.97 Million
-0.702x +0.45%
2012-12-31 Skr17.09 Million
≈ $1.84 Million
Skr-12.05 Million
≈ $-1.30 Million
-0.705x -28.07%
2011-12-31 Skr10.83 Million
≈ $1.17 Million
Skr-5.96 Million
≈ $-641.36K
-0.550x -15.89%
2010-12-31 Skr10.36 Million
≈ $1.11 Million
Skr-4.92 Million
≈ $-529.25K
-0.475x -38.16%
2009-12-31 Skr6.63 Million
≈ $713.34K
Skr-2.28 Million
≈ $-245.16K
-0.344x -1723.94%
2008-12-31 Skr3.68 Million
≈ $395.79K
Skr-69.30K
≈ $-7.46K
-0.019x --

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices
Market Cap
$6.27 Million
Skr58.28 Million SEK
Market Cap Rank
#28105 Global
#625 in Sweden
Share Price
Skr1.87
Change (1 day)
-1.27%
52-Week Range
Skr1.87 - Skr11.82
All Time High
Skr1089.26
About

Clinical Laserthermia Systems AB (publ) engages in the development of treatment tools for diseased tissue under the TRANBERG brand in Sweden. It offers TRANBERG, a thermal therapy system designed to deliver laser energy to heat the target tissue. The company also provides mobile laser unit, a controlling component with a wavelength of 1064 nanometers that provides multiple options to control trea… Read more